Loading fund…
Loading fund…
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | ▲ +0.8% | ▲ +4.4% | ▲ +3.6% | ▲ +21.1% | ▲ +18.4% | — | — | ▲ +22.9% |
| Peer average | — | — | — | — | — | — | — | — |
| S&P 500 · VOO | ▼ −0.4% | ▲ +0.9% | ▲ +3.3% | ▲ +13.8% | ▲ +13.3% | ▲ +88.8% | ▲ +81.9% | — |
The SMI 3Fourteen Full-Cycle Trend ETF (FCTE) seeks to outperform the S&P 500 index throughout entire market cycles by strategically investing in what it identifies as the most promising companies. Its portfolio typically comprises around 20 large-capitalization U.S. equities, all drawn from the S&P 500. Investment decisions are guided by the proprietary Full-Cycle Trend (FCT) strategy, which thoroughly evaluates stocks based on various quality and trend-related metrics. These include a company's capital efficiency (such as return on capital and return on investment), financial stability (like cash flow consistency), growth potential (earnings growth), market sentiment (momentum), and technical analysis (including linear regression and broader trend assessments). Each month, a theoretical model portfolio is constructed and published. The fund's adviser uses this model to rebalance holdings on a monthly basis, though they retain discretion to make additional adjustments or deviate from the model due to regulatory considerations or significant stock volatility. This fund may also engage in frequent and active trading.
Distribution yield and SEC yield use different methodologies. Payouts may include income, capital gains, or return of capital.
| Ex-date | Pay date | Per share |
|---|---|---|
| 2025-12-24 | 2025-12-26 | $0.02 |
| 2025-03-19 | 2025-03-20 | $0.02 |
| 2024-12-24 | 2024-12-26 | $0.02 |
| 2024-09-26 | 2024-09-27 | $0.03 |
Estimated annual expense excludes trading costs and assumes constant assets. Fee waivers and fund costs can change.
Historical risk measures describe past behavior and do not predict future returns.
Hear the strategy from the people behind FCTE.